# 28 CFR 202.510 Drug, biological product, and medical device authorizations.

28 CFR 202.510 Drug, biological product, and medical device authorizations., “Drug, biological product, and medical device authorizations”, is a CFR section of [28 CFR Part 202, Subpart E—Exempt Transactions](https://ontology.bommaritollc.com/id/01a0f09b-7ffd-725f-b761-51ef00364b39); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f09b-8a0b-7783-908b-c635e44ded71>

Within: [Title 28—Judicial Administration](https://ontology.bommaritollc.com/id/01a0f09b-7f03-7047-8e93-93df7dea49ba) › [28 CFR Chapter I—DEPARTMENT OF JUSTICE](https://ontology.bommaritollc.com/id/01a0f09b-7f24-73b3-9363-f5283c32b55a) › [28 CFR Part 202—Access to U.S. sensitive personal data and government-related data by countries of concern or covered persons](https://ontology.bommaritollc.com/id/01a0f09b-810b-7639-8e84-9bd70e9058a6) › [28 CFR Part 202, Subpart E—Exempt Transactions](https://ontology.bommaritollc.com/id/01a0f09b-7ffd-725f-b761-51ef00364b39)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 28 CFR 202.510](https://ontology.bommaritollc.com/id/01a0f09b-8a0c-72b2-811a-5bffd144cf33)
- `eli:cites`:
  - [21 U.S.C. 21 Branding grades on barrels of apples](https://ontology.bommaritollc.com/id/01a0f06c-cc1e-736f-8f57-766540602cee)
  - [21 U.S.C. 321 Definitions; generally](https://ontology.bommaritollc.com/id/01a0f06c-cc8c-7030-ab68-1def0b197dcb)
  - [42 U.S.C. 262 Regulation of biological products](https://ontology.bommaritollc.com/id/01a0f07c-d9ca-7203-a1d8-2d79c0329140)
  - [21 CFR 3.2 Definitions.](https://ontology.bommaritollc.com/id/01a0f094-ba45-70e0-88f8-3db5b705a656)
  - [21 CFR 314.80 Postmarketing reporting of adverse drug experiences.](https://ontology.bommaritollc.com/id/01a0f094-c4c4-715e-9bae-f809f18f5dcb)
  - [28 CFR Part 202—Access to U.S. sensitive personal data and government-related data by countries of concern or covered persons](https://ontology.bommaritollc.com/id/01a0f09b-810b-7639-8e84-9bd70e9058a6)
  - [28 CFR 202.1101 Records and recordkeeping requirements.](https://ontology.bommaritollc.com/id/01a0f09b-8a13-7234-99d8-7b609c9593cf)
  - [28 CFR 202.1102 Reports to be furnished on demand.](https://ontology.bommaritollc.com/id/01a0f09b-8a14-7788-bb39-bd1757db941e)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title28-vol1](https://ontology.bommaritollc.com/id/01a0f09b-8a0b-7783-908b-c634868a5f69)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f09b-922c-74f7-b587-544ac6cad97a)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d1-02ad-7705-ba55-b314625b4bf5)
  - [evidence from https://www.govinfo.gov/link/cfr/28/202?sectionnum=510&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-9a6d-74ff-bcbb-3e81b2ccc5bf)
- `schema:isPartOf`: [28 CFR Part 202, Subpart E—Exempt Transactions](https://ontology.bommaritollc.com/id/01a0f09b-7ffd-725f-b761-51ef00364b39)
- `schema:legislationIdentifier`: 28 CFR 202.510
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Drug, biological product, and medical device authorizations
- `schema:url`: [https://www.govinfo.gov/link/cfr/28/202?sectionnum=510&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/28/202?sectionnum=510&year=mostrecent&link-type=details)
- `skos:prefLabel`: 28 CFR 202.510 Drug, biological product, and medical device authorizations.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/28/202?sectionnum=510&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title28-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f09b-8a0b-7783-908b-c635e44ded71.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f09b-8a0b-7783-908b-c635e44ded71.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f09b-8a0b-7783-908b-c635e44ded71.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f09b-8a0b-7783-908b-c635e44ded71)
Cite as: 28 CFR 202.510 Drug, biological product, and medical device authorizations.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f09b-8a0b-7783-908b-c635e44ded71
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
